Diabetes drugs in clinical trials
Profil Germany supports the full range of early-phase trials required for the clinical development of novel solutions for diabetes, prediabetes and obesity. Our core expertise covers all of the essential methods for diabetes medication clinical trials, including glucose clamp studies, pharmacokinetic and pharmacodynamic studies, safety and tolerability studies, and bioequivalence or bridging studies. With hundreds of studies in many drug discovery projects to our name, we have the experience and knowledge to be the perfect partner for clinical trials.
Our clinical development consulting team will aid you in developing the study design that generates the necessary data to achieve critical goals, such as product registration in the EU or North America or out-licensing or selling of an IP.
Read on to discover more about the specialized services we offer in the clinical development of diabetes treatments.